Pharmanovia is a global pharmaceutical company focused on acquiring, revitalizing, and commercializing legacy medicines to improve patient access. It handles development, regulatory affairs, manufacturing, and worldwide commercialization of these medicines. The company aims to extend the lifecycle of established therapies through partnerships and optimized commercialization across markets.
AI named Valium in September 2026.
Brand page for pharmanovia-com